相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular Disease Mortality Among Breast Cancer Survivors
Patrick T. Bradshaw et al.
EPIDEMIOLOGY (2016)
Chelerythrine chloride induces apoptosis in renal cancer HEK-293 and SW-839 cell lines
Xiao-Meng Chen et al.
ONCOLOGY LETTERS (2016)
Activation of p53-dependent/-independent pathways of apoptotic cell death by chelerythrine in a murine T cell lymphoma
Sanjay Kumar et al.
LEUKEMIA & LYMPHOMA (2015)
Triple-negative breast cancer: new perspectives for targeted therapies
Federica Tomao et al.
ONCOTARGETS AND THERAPY (2015)
Metabolic Syndrome and Breast Cancer: Is There a Link?
Dagmar Hauner et al.
BREAST CARE (2014)
Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast Cancer
Yi-Hsin Hsu et al.
CANCER RESEARCH (2014)
New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity
Ingrid A. Mayer et al.
CLINICAL CANCER RESEARCH (2014)
Protein kinase C and cancer: what we know and what we do not
R. Garg et al.
ONCOGENE (2014)
Chelerythrine induces reactive oxygen species-dependent mitochondrial apoptotic pathway in a murine T cell lymphoma
Sanjay Kumar et al.
TUMOR BIOLOGY (2014)
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
Wai Leong Tam et al.
CANCER CELL (2013)
Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
Bonnie Ky et al.
CIRCULATION RESEARCH (2013)
A benzophenanthridine alkaloid, chelerythrine induces apoptosis in vitro in a Dalton's lymphoma
Sanjay Kumar et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2013)
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Sarah C. Darby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Emerging targeted therapies in triple-negative breast cancer
J. Crown et al.
ANNALS OF ONCOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Protein kinase C, an elusive therapeutic target?
Daria Mochly-Rosen et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
PKC alpha and ER beta Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients
Debra A. Tonetti et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Induction of Apoptosis by Chelerythrine Chloride through Mitochondrial Pathway and Bcl-2 Family Proteins in Human Hepatoma SMMC-7721 Cell
Zheng-fu Zhang et al.
ARCHIVES OF PHARMACAL RESEARCH (2011)
Regulatory Domain Selectivity in the Cell-Type Specific PKN-Dependence of Cell Migration
Sylvie Lachmann et al.
PLOS ONE (2011)
Reactive oxygen species-independent rapid initiation of mitochondrial apoptotic pathway by chelerythrine
Takeshi Funakoshi et al.
TOXICOLOGY IN VITRO (2011)
The association of metabolic syndrome with triple-negative breast cancer
B. Maiti et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
PKCα expression is a marker for breast cancer aggressiveness
Gry Kalstad Lonne et al.
MOLECULAR CANCER (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
PKC and the control of localized signal dynamics
Carine Rosse et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pattern of metastatic spread in triple-negative breast cancer
Rebecca Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
Carey K. Anders et al.
CLINICAL BREAST CANCER (2009)
PKC Isozymes in chronic cardiac disease: Possible therapeutic targets?
Eric Churchill et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population
Linda Vona-Davis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Activation of the RAF/Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Mediates Apoptosis Induced by Chelerythrine in Osteosarcorna
Rui Yang et al.
CLINICAL CANCER RESEARCH (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Epidemiology of basal-like breast cancer
Robert C. Millikan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Protein kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells
Lisa B. Frankel et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis
Anja Schmidt et al.
EMBO JOURNAL (2007)
The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine
J. Malikova et al.
CELL BIOLOGY AND TOXICOLOGY (2006)
Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine
Adam Kemeny-Beke et al.
CANCER LETTERS (2006)
The beneficial in vitro effects of lovastatin and chelerythrine on relaxatory response to acetylcholine in the perfused mesentric bed isolated from diabetic rats
Z Fatehi-Hassanabad et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Protein kinase C ζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells
RH Sun et al.
CANCER RESEARCH (2005)
Probabilities of death from breast cancer and other causes among female breast cancer patients
C Schairer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure
DA Tonetti et al.
BRITISH JOURNAL OF CANCER (2003)
Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion
E Calautti et al.
JOURNAL OF CELL BIOLOGY (2002)
The protein kinase C-related kinase PRK2 interacts with the protein tyrosine phosphatase PTP-BL via a novel PDZ domain binding motif
C Gross et al.
FEBS LETTERS (2001)
Inhibition of Akt and its anti-apoptotic activities by tumor necrosis factor-induced protein kinase C-related kinase 2 (PRK2) cleavage
H Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Stable transfection of protein kinase C alpha cDNA in hormone dependent breast cancer cell lines
DA Tonetti et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
